Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoproliferative Disorders × cirmtuzumab × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 2 Neoplasms 1 Breast Neoplasms 1

Interventions

fludarabine 5 fludarabine phosphate 4 Cyclophosphamide 4 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 Bendamustine Hydrochloride 2 AP 1903 reagent 2 isatuximab 1 ibrutinib 1 enzalutamide 1 Lenalidomide 1 Dexamethasone 1 CA-4948 1 Bortezomib 1 Bone Marrow Transplantation 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡